15 reports of this reaction
2.2% of all ASPIRIN AND CAFFEINE reports
#6 most reported adverse reaction
DYSPNOEA is the #6 most commonly reported adverse reaction for ASPIRIN AND CAFFEINE, manufactured by Medtech Products Inc.. There are 15 FDA adverse event reports linking ASPIRIN AND CAFFEINE to DYSPNOEA. This represents approximately 2.2% of all 684 adverse event reports for this drug.
Patients taking ASPIRIN AND CAFFEINE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for ASPIRIN AND CAFFEINE, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for ASPIRIN AND CAFFEINE:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 15 FDA reports for ASPIRIN AND CAFFEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 2.2% of all adverse event reports for ASPIRIN AND CAFFEINE, making it a notable side effect.
If you experience dyspnoea while taking ASPIRIN AND CAFFEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.